Longevity Health (NASDAQ:XAGE – Get Free Report) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX – Get Free Report) are both small-cap manufacturing companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation and institutional ownership.
Earnings & Valuation
This table compares Longevity Health and Inspira Technologies OXY B.H.N.”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Longevity Health | $1.05 million | 0.44 | -$10.37 million | ($4.29) | -0.06 |
| Inspira Technologies OXY B.H.N. | $290,000.00 | 159.92 | -$13.22 million | N/A | N/A |
Volatility and Risk
Longevity Health has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.06, indicating that its share price is 306% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent recommendations for Longevity Health and Inspira Technologies OXY B.H.N., as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Longevity Health | 0 | 0 | 0 | 0 | 0.00 |
| Inspira Technologies OXY B.H.N. | 1 | 0 | 0 | 0 | 1.00 |
Insider & Institutional Ownership
24.2% of Longevity Health shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 29.0% of Longevity Health shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Profitability
This table compares Longevity Health and Inspira Technologies OXY B.H.N.’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Longevity Health | -682.67% | N/A | -261.90% |
| Inspira Technologies OXY B.H.N. | N/A | N/A | N/A |
Summary
Inspira Technologies OXY B.H.N. beats Longevity Health on 6 of the 9 factors compared between the two stocks.
About Longevity Health
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
About Inspira Technologies OXY B.H.N.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra’annana, Israel.
Receive News & Ratings for Longevity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longevity Health and related companies with MarketBeat.com's FREE daily email newsletter.
